Peri-tumor administration of 5-fluorouracil sol-gel using a hollow microneedle for treatment of gastric cancer

References

• Aaron DuVall G, Tarabar D, Seidel RH, et al. (2009). Phase 2: a dose-escalation study of OncoGel (ReGel/paclitaxel), a controlled-release formulation of paclitaxel, as adjunctive local therapy to external-beam radiation in patients with inoperable esophageal cancer. Anti-Cancer Drugs 20:89–95.
   PubMed Web of Science ®Google Scholar
• Armstrong DK, Fleming GF, Markman M, Bailey HH. (2006). A phase I trial of intraperitoneal sustained-release paclitaxel microspheres (Paclimer) in recurrent ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol 103:391–6.
   PubMed Web of Science ®Google Scholar
• Brimhall B, Adler DG. (2011). Enteral stents for malignant gastric outlet obstruction. Gastrointest Endosc Clin N Am 21:389–403.
   PubMedGoogle Scholar
• Calabro-Jones PM, Byfield JE, Ward JF, Sharp TR. (1982). Time-dose relationships for 5-fluorouracil cytotoxicity against human epithelial cancer cells in vitro. Cancer Res 42:4413–20.
   PubMed Web of Science ®Google Scholar
• Cheema U, Rong Z, Kirresh O, et al. (2012). Oxygen diffusion through collagen scaffolds at defined densities: implications for cell survival in tissue models. J Tissue Eng Regen Med 6:77–84.
   PubMed Web of Science ®Google Scholar
• Chung TW, Lin SY, Liu DZ, et al. (2009). Sustained release of 5-FU from Poloxamer gels interpenetrated by crosslinking chitosan network. Int J Pharm 382:39–44.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, et al. (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–86.
   PubMed Web of Science ®Google Scholar
• Fraile RJ, Baker LH, Buroker TR, et al. (1980). Pharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusion. Cancer Res 40:2223–8.
   PubMed Web of Science ®Google Scholar
• Fukunaga H, Katsumi M, Aoki Y, Oka S. (1987). 5-FU concentration in tumor tissue and the antitumor effect in patients with gastric cancer after oral administration of UFT. Gan to Kagaku Ryoho 14:2735–9.
   PubMedGoogle Scholar
• Glen CD, Dubrova YE. (2012). Exposure to anticancer drugs can result in transgenerational genomic instability in mice. Proc Natl Acad Sci USA 109:2984–8.
   PubMed Web of Science ®Google Scholar
• Hall PA, Coates PJ, Ansari B, Hopwood D. (1994). Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. J Cell Sci 107 (Pt 12):3569–77.
   PubMed Web of Science ®Google Scholar
• Hohenforst-Schmidt W, Zarogoulidis P, Darwiche K, et al. (2013). Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies. Drug Des Devel Ther 7:571–83.
   PubMed Web of Science ®Google Scholar
• Jeurnink SM, Steyerberg EW, Hof GV, et al. (2007). Gastrojejunostomy versus stent placement in patients with malignant gastric outlet obstruction: a comparison in 95 patients. J Surg Oncol 96:389–96.
   PubMed Web of Science ®Google Scholar
• Jeurnink SM, Steyerberg EW, van Hooft JE, Dutch SUSTENT Study Group, et al. (2010). Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial. Gastrointest Endosc 71:490–9.
   PubMed Web of Science ®Google Scholar
• Jones NL, Shannon PT, Cutz E, et al. (1997). Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection. Am J Pathol 151:1695–703.
   PubMed Web of Science ®Google Scholar
• Jun H, Han MR, Kang NG, et al. (2015). Use of hollow microneedles for targeted delivery of phenylephrine to treat fecal incontinence. J Control Release 207:1–6.
   PubMed Web of Science ®Google Scholar
• Kong SH, Park DJ, Lee HJ, et al. (2004). Clinicopathologic features of asymptomatic gastric adenocarcinoma patients in Korea. Jpn J Clin Oncol 34:1–7.
   PubMed Web of Science ®Google Scholar
• Li KW, Dang W, Tyler BM, et al. (2003). Polilactofate microspheres for Paclitaxel delivery to central nervous system malignancies. Clin Cancer Res 9:3441–7.
   PubMed Web of Science ®Google Scholar
• Ly J, O'Grady G, Mittal A, et al. (2010). A systematic review of methods to palliate malignant gastric outlet obstruction. Surg Endosc 24:290–7.
   PubMed Web of Science ®Google Scholar
• Meta-analysis Group In Cancer, Piedbois P, Rougier P, Buyse M, et al. (1998). Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol 16:301–8.
   PubMed Web of Science ®Google Scholar
• Minchinton AI, Tannock IF. (2006). Drug penetration in solid tumours. Nat Rev Cancer 6:583–92.
   PubMed Web of Science ®Google Scholar
• Modok S, Scott R, Alderden RA, et al. (2007). Transport kinetics of four- and six-coordinate platinum compounds in the multicell layer tumour model. Br J Cancer 97:194–200.
   PubMed Web of Science ®Google Scholar
• Nakase Y. (2004). Intratumoral administration of methotrexate bound to activated carbon particles: antitumor effectiveness against human colon carcinoma xenografts and acute toxicity in mice. J Pharmacol Exp Ther 311:382–7.
   PubMed Web of Science ®Google Scholar
• Ruel-Gariépy E, Leroux J-C. (2004). In situ-forming hydrogels–review of temperature-sensitive systems. Eur J Pharm Biopharm 58:409–26.
   PubMed Web of Science ®Google Scholar
• Unosson J, Montufar EB, Engqvist H, et al. (2016). Brushite foams–the effect of Tween® 80 and Pluronic® F-127 on foam porosity and mechanical properties. J Biomed Mater Res 104:67–77.
   Web of Science ®Google Scholar
• Witt KL, Bishop JB. (1996). Mutagenicity of anticancer drugs in mammalian germ cells. Mutat Res 355:209–34.
   PubMed Web of Science ®Google Scholar